Prednisolone Dosing Guidelines for Autoimmune Conditions

Disease-Specific Dosing Recommendations

The British Journal of Dermatology recommends a dose of 0.75-1 mg/kg/day for severe/widespread bullous pemphigoid, 0.3 mg/kg/day for moderate disease, and 0.5 mg/kg/day for mild/localized disease 1, 2
For pemphigus vulgaris, the British Journal of Dermatology suggests an initial dose of 1-2 mg/kg/day, with milder cases potentially managed with 0.5-1 mg/kg/day 3, 4, 2
If no response is seen within 5-7 days, the dose should be increased by 50-100% increments, with consideration for pulsed IV corticosteroids if doses exceed 1 mg/kg/day 3, 4, 5
The Mayo Clinic recommends an initial dose of 0.5-1 mg/kg/day for dermatomyositis/polymyositis, with a tapering schedule to minimize side effects 6

The British Journal of Dermatology advises against exceeding 1 mg/kg/day without considering pulsed IV methylprednisolone due to increased mortality risk 1, 3, 4, 5
For long-term therapy, alternate-day dosing may reduce adverse effects, according to Praxis Medical Insights 7
The British Journal of Dermatology notes that very high doses (>1 mg/kg/day) carry significant mortality risk, particularly in elderly patients with comorbidities 1

The British Journal of Dermatology highlights a dose-response paradox in pemphigus vulgaris, where low-dose and high-dose prednisolone showed no difference in disease control or relapse rates at 5 years 3, 4, 5
Praxis Medical Insights recommends calcium and vitamin D supplementation for all patients on long-term therapy, as well as regular DEXA scanning 7
The British Journal of Dermatology considers prednisolone and prednisone bioequivalent, with single daily dosing as the standard for most conditions 1, 7